Avita Medical (RCEL) SEC Filings: History & Chart

Avita Medical Inc.(RCEL)

Medical - Devices · Valencia, CA

$12.99-0.26 (-1.96%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Avita Medical Inc.

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.

Valencia, CA

226 employees

avitamedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Cary G. Vance

View full financials

Form	Filing Date	Accepted	Document
S-8	Aug 25, 2026	Aug 25, 2026	View filing
4/A	Aug 24, 2026	Aug 24, 2026	View filing
8-K	Aug 11, 2026	Aug 11, 2026	View filing
8-K/A	Aug 6, 2026	Aug 6, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 10, 2026	Jun 10, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
8-K	Jun 8, 2026	Jun 5, 2026	View filing
424B5	Jun 8, 2026	Jun 5, 2026	View filing
4	Jun 5, 2026	Jun 5, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
8-K	Jun 4, 2026	Jun 3, 2026	View filing
4	Jun 1, 2026	Jun 1, 2026	View filing
4	Jun 1, 2026	Jun 1, 2026	View filing
4	May 20, 2026	May 20, 2026	View filing
4	May 19, 2026	May 19, 2026	View filing
10-Q	May 14, 2026	May 14, 2026	View filing
8-K	May 14, 2026	May 14, 2026	View filing
8-K	May 1, 2026	May 1, 2026	View filing
DEF 14A	Apr 22, 2026	Apr 22, 2026	View filing
EFFECT	Apr 9, 2026	Apr 10, 2026	View filing
PRE 14A	Apr 8, 2026	Apr 8, 2026	View filing
S-3	Mar 31, 2026	Mar 31, 2026	View filing

SEC Filings

Recent Filings